Compounds antagonistic to norepinephrine retention by rat brain homogenates.
D000818:Animals; D001679:Biogenic Amines / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002396:Catechols / Q000494:pharmacology; D003864:Depression, Chemical; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D009655:Octopamine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D010648:Phenylacetates / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology; D014642:Vanilmandelic Acid / Q000494:pharmacology
D001679:Biogenic Amines; D002396:Catechols; D010627:Phenethylamines; D010648:Phenylacetates; D014316:Tritium; D009655:Octopamine; D014642:Vanilmandelic Acid; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine